Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: marks (231), results (1000)

Carfilzomib(14 day)-Dexamethasone(20) Ver1

Description: Chemotherapy Protocol MYELOMA Carfilzomib (14 day)-Dexamethasone (20) Regimen  Myeloma – Carfilzomib-Dexamethasone (20) Indication  Carfilzomib in combination with dexamethasone is an
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/carfilzomib14-day-dexamethasone20-ver1.pdf

Irinotecan-Temozolomide

Description: Chemotherapy Protocol Sarcoma IRINOTECAN - TEMOZOLOMIDE Regimen • Sarcoma – Irinotecan-Temozolomide Indication • Recurrent or progressive Ewings sarcoma • Performance status 0, 1, 2 Toxicity
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Irinotecan-Temozolomide.pdf

InPEtoposideIfosfamide(5dy)Ver1

Description: Chemotherapy Protocol SARCOMA ETOPOSIDE-IFOSFAMIDE (5 day) Inpatient Regimen Regimen Sarcoma-InP-Etoposide-Ifosfamide (5 day) Indication Second line treatment of
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InPEtoposideIfosfamide5dyVer1.pdf

InP Ifosfamide(2day)Ver1

Description: Chemotherapy Protocol SARCOMA IFOSFAMIDE (2 day) Inpatient Regimen Regimen Sarcoma-InP-Ifosfamide (2 day) Indication Advanced or metastatic soft tissue sarcoma
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InPIfosfamide2dayVer1.pdf

Lenvatinib(60kg or greater)

Description: Chemotherapy Protocol HEPATOCELLULAR CANCER LENVATINIB (60kg or greater) Regimen • Hepatocellular – Lenvatinib Indication • Lenvatinib is indicated where either; - the patient has a
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Lenvatinib-60kg-or-greater-Ver1.pdf

Lenvatinib(59kg or less)

Description: Chemotherapy Protocol HEPATOCELLULAR CANCER LENVATINIB (59kg or less) Regimen • Hepatocellular – Lenvatinib Indication • Lenvatinib is indicated where either; - the patient has a
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Lenvatinib-59kg-or-less-.pdf

Cisplatin-Gemcitabine Ver 2.1

Description: Chemotherapy Protocol PANCREATIC CANCER CISPLATIN-GEMCITABINE (RADIOTHERAPY) Regimen Pancreatic Cancer – Cisplatin-G
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Pancreas/Cisplatin-GemcitabineVer21.pdf

Fluorouracil-Mitomycin-Radiotherapy

Description: Chemotherapy Protocol COLORECTAL CANCER FLUOROURACIL-MITOMYCIN-RADIOTHERAPY Regimen • Colorectal Cancer – Fluorouracil-Mitomycin-Radiotherapy Indication • Squamous cell carcinoma of the anus • WHO
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Fluorouracil-Mitomycin-Radiotherapy.pdf

Temozolomide RT (7 day)

Description: Chemotherapy Protocol Central Nervous System TEMOZOLOMIDE RT (7 day) Regimen • CNS – Temozolomide RT (7 day) Indication • First line treatment of newly
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Temozolomide-RT-7-day.pdf

Southampton PTC - Approved chemotherapy regimens 9 June 2020

Description: Appendix B: SOUTHAMPTON PAEDIATRIC ONCOLOGY PRINCIPAL TREATMENT CENTRE List of Approved Chemotherapy Regimens Updated 9th June 2020 Review Date: June 2021
Url: /Media/UHS-website-2019/Docs/PaediatricOncology/Southampton-PTC-Approved-chemotherapy-regimens-9-June-2020.pdf

301 to 310 of 548

Previous … 29 30 31 32 33 … Next